Tianhong Hang Seng Shanghai-Shenzhen-H.K Inno Drug Select 50 Index ETF (SHA:517380)

Assets	n/a
Expense Ratio	n/a
PE Ratio	n/a
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a
1-Year Return	+4.67%

Volume	113,396,198
Open	0.9030
Previous Close	0.9000
Day's Range	0.8890 - 0.9080
52-Week Low	0.6210
52-Week High	0.9350
Beta	0.42
Holdings	88
Inception Date	Jul 27, 2021

About 517380

TianHong Asset Management Corp. Ltd. - Th Innovative Drug 50 Etf is headquartered in China.

• Asset Class: Equity
• Category: Health Care
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 517380
• Provider: Tianhong
• Index Tracked: Hang Seng Shanghai-Shenzhen-Hong Kong Innovative Drug Select 50 Index - CNY - Benchmark TR Gross

Performance

517380 had a total return of 4.67% in the past year, including dividends. Since the fund's inception, the average annual return has been -1.65%.

Top 10 Holdings

67.44% of assets

Name	Symbol	Weight
WuXi AppTec Co., Ltd.	603259	15.72%
Jiangsu Hengrui Pharmaceuticals Co.,Ltd	600276	12.96%
BeOne Medicines AG	6160	10.76%
WuXi Biologics (Cayman) Inc.	2269	7.08%
Innovent Biologics, Inc.	1801	6.83%
WuXi AppTec Co., Ltd.	2359	3.88%
CSPC Pharmaceutical Group Limited	1093	2.93%
Sichuan Kelun Pharmaceutical Co., Ltd.	002422	2.59%
Sino Biopharmaceutical Limited	1177	2.37%
Hansoh Pharmaceutical Group Company Limited	3692	2.33%

Data Sources: S&P Global Market Intelligence and Finnhub

Historical data is provided by S&P Global Market Intelligence. Several fund data points are also provided by Finnhub.

Last checked:

Sep 23, 2026

Data Sources Report a data error